BioSpace News Archive

Press Releases

AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference

February 17, 2026
·
1 min read
Press Releases

Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement

February 17, 2026
·
6 min read
Press Releases

Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company

February 17, 2026
·
4 min read
Press Releases

BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics

February 17, 2026
·
2 min read
Press Releases

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

February 17, 2026
·
3 min read
Press Releases

Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer

February 17, 2026
·
3 min read
Press Releases

Incyte to Present at Upcoming March 2026 Investor Conferences

February 17, 2026
·
1 min read
Press Releases

Leading the Next Wave of Innovative IBD Therapeutics Targeting Immunometabolism: Josep Bassaganya-Riera Launches Clinical Program and Business Venture to Develop NIM-1324 for Ulcerative Colitis and Crohn’s disease

February 17, 2026
·
5 min read
Press Releases

Novo Nordisk A/S: The European Commission approves more effective dose of injectable Wegovy® for adults with obesity; clinical study showed people lost about 21% of their body weight on average

February 17, 2026
·
4 min read
Press Releases

Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)

February 17, 2026
·
3 min read